Screening compound: InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3

Screening compound: InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3
Screening compound: InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5350-0713

Molecular Formula

C16H13ClN2OS (C16 H13 ClN2 OS)

Compound Name

2-(3-chlorobenzoyl)-4,6-dimethylthieno[2,3-b]pyridin-3-amine

IUPAC name

2-(3-chlorobenzoyl)-46-dimethylthieno[23-b]pyridin-3-amine

SMILES

Cc1cc(C)nc2c1c(N)c(C(c1cccc(Cl)c1)=O)s2

InChI

InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3

InChI Key

DFIAMGCGHLHXSS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03015552

InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anti-Aging Library (44940 compounds)

Antifungal Library (16415 compounds)

Antiviral Annotated Library (21441 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
Agro:
  • Agro
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3?
Check Price and Availability of InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C16H13ClN2OS/c1-8-6-9(2)19-16-12(8)13(18)15(21-16)14(20)10-4-3-5-11(17)7-10/h3-7H,18H2,1-2H3 available by request